Cathie Wood says her firm is testing a more aggressive strategy that would be ‘ARK on steroids’


Cathie Wood — known for her innovation ETFs that garnered billions in inflows during the pandemic — said Ark Invest is internally testing a fund that takes the strategy a step further by simultaneously betting against major stocks in the benchmarks that are being disrupted.

“We’re testing out a portfolio but it’s really Ark on steroids,” Wood told CNBC’s “Squawk Box” on Wednesday. Wood said she wants to test the strategy on Ark’s employees and did not say when the fund would be made available to retail investors.

“We think the benchmarks are where the big risks are long-term because they are filling up with value-traps, those companies that have done very well historically but are…


0 0 votes
Article Rating

Unusual holiday home-buying surge pushes mortgage demand higher

Previous article

Cathie Wood says Apple should’ve bought Tesla, but ‘we’re happy they didn’t’

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Investing